Home Cart Sign in  
Chemical Structure| 172152-36-2 Chemical Structure| 172152-36-2

Structure of Ilaprazole
CAS No.: 172152-36-2

Chemical Structure| 172152-36-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ilaprazole inhibited TOPK activities with high affinity and selectivity.

Synonyms: IY-81149; (R,S)-Ilaprazole

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ilaprazole

CAS No. :172152-36-2
Formula : C19H18N4O2S
M.W : 366.44
SMILES Code : O=S(C1=NC2=CC=C(N3C=CC=C3)C=C2N1)CC4=NC=CC(OC)=C4C
Synonyms :
IY-81149; (R,S)-Ilaprazole
MDL No. :MFCD00942538
InChI Key :HRRXCXABAPSOCP-UHFFFAOYSA-N
Pubchem ID :214351

Safety of Ilaprazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Proton Pump

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03444883 Non-erosive Reflux Disease PHASE3 COMPLETED 2020-02-25 Seoul National University Bund... More >>ang Hospital, Seongnam-si, Bundang-gu, Korea, Republic of|Inje University Busan Paik Hospital, Busan, Busanjin-gu, Korea, Republic of|Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Dongjak-gu, Korea, Republic of|Chonbuk National University Hospital, Jeonju, Jeonju-si, Korea, Republic of|Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Jongno-gu, Korea, Republic of|Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of|Inje University Seoul Paik Hospital, Seoul, Jung-gu, Korea, Republic of|Severance Hospital Yonsei University Health System, Seoul, Seodaemun-gu, Korea, Republic of|Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of|Soon Chun Hyang University Hospital, Buchon, Bucheon, Wonmi-gu, Korea, Republic of|Ewha Womans University Mokdong Hospital, Seoul, Yangcheon-gu, Korea, Republic of Less <<
NCT01688544 Healthy PHASE1 COMPLETED 2025-12-11 Inje University Busan Paik Hoa... More >>pital Clinical Trial Center, Busan, 614-735, Korea, Republic of Less <<
NCT02666976 Gastrointestinal Subepithelial... More >> Tumors Less << PHASE4 COMPLETED 2025-01-16 Severance Hospital, Seoul, 037... More >>22, Korea, Republic of Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.73mL

0.55mL

0.27mL

13.64mL

2.73mL

1.36mL

27.29mL

5.46mL

2.73mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories